Uncategorised - European Medical Journal

bronchiestasis

New International Guidelines Set Standard for Bronchiectasis Care

The ERS has released evidence-based guidelines for adult bronchiectasis care, offering structured recommendations on airway clearance, macrolides, and inhaled antibiotics.

cognitive impairment

PET Imaging Study Links Synaptic Changes to Long COVID Cognitive Impairment

A PET imaging study reveals widespread synaptic AMPAR increases in long COVID patients with cognitive impairment.

depression

Personalised Transcranial Stimulation Shows Promise for Depression Treatment

This study supports HD-tDCS as a safe, fast-acting, and effective non-invasive option for depression treatment.

type 2 diabetes

Carnosine and β-alanine Show Promise in Type 2 Diabetes

Learn how carnosine and β-alanine may improve blood sugar and β-cell function in Type 2 diabetes and prediabetes.

The latest issue of EMJ Cardiology

Featuring unmissable insights from the ESC Congress 2025. Inside, discover the latest in cardiology news and breakthroughs, including an…

UEG Week 2025: Semaglutide Improves MASH Histology Through Weight-Independent Mechanisms

New ESSENCE trial data show semaglutide improves liver histology and non-invasive markers in MASH through mechanisms beyond weight loss, highlighting dual metabolic benefits.

UEG Week 2025: Europe Faces Rising Liver Cancer Epidemic

New joint statement from United European Gastroenterology and the German Society for Gastroenterology calls for coordinated prevention, early detection, and policy reform to reverse the rising tide of liver cancer across Europe.

Explainable AI and Chatbot-Enabled ACS Mortality Prediction in Asian Populations

ST-elevation myocardial infarction (STEMI) is a leading cause of mortality, with significant variations in risk profiles among the Asian…

Review of the European Society of Cardiology (ESC) Congress 2025

With three-quarters of a century dedicated to advancing cardiovascular science and improving patient care, the ESC President…

MAPLE-HCM: Aficamten vs Metoprolol in Obstructive HCM

Beta-blockers have been the cornerstone of treatment for obstructive hypertrophic cardiomyopathy for almost 6 years. Recent data from…